wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q57330076-9B587BCC-4ADB-41A9-A856-E9591CB8E0A8
Q57330076-9B587BCC-4ADB-41A9-A856-E9591CB8E0A8
BestRank
Statement
http://www.wikidata.org/entity/statement/Q57330076-9B587BCC-4ADB-41A9-A856-E9591CB8E0A8
Comparative efficacy and tolerability of sarilumab 150 and 200 mg in patients with active rheumatoid arthritis
P2860
Q57330076-9B587BCC-4ADB-41A9-A856-E9591CB8E0A8
BestRank
Statement
http://www.wikidata.org/entity/statement/Q57330076-9B587BCC-4ADB-41A9-A856-E9591CB8E0A8
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
d2073ac428da31b67b0008adca868e98ce2438bf
P2860
Efficacy and safety of sarilumab monotherapy versus adalimumab monotherapy for the treatment of patients with active rheumatoid arthritis (MONARCH): a randomised, double-blind, parallel-group phase III trial.